Laboratorio Reig Jofre, S.A.
RJF
Rank in Stocks
#15753
Laboratorio Reig Jofre, S.A. is a pharmaceutical company dedicated to the... Laboratorio Reig Jofre, S.A. is a pharmaceutical company dedicated to the research, development, manufacturing, and commercialization of a diverse range of medicines and nutritional supplements. Its extensive portfolio encompasses prescription drugs, over-the-counter (OTC) products, medical devices, and cosmetics. The company's offerings are categorized into several key areas: advanced pharmaceutical technologies, which include antibiotics and injectable formulations; specialized healthcare solutions targeting dermatological, musculoskeletal (joint health and pain), women's health, respiratory/ENT, and pediatric needs; and consumer health items marketed under its Forté Pharma brand. Furthermore, Laboratorio Reig Jofre provides contract development and manufacturing (CDMO) as well as contract manufacturing organization (CMO) services. Founded in 1929 and headquartered in Sant Joan Despí, Spain, the company sells its products directly in seven countries and collaborates with business partners to reach approximately 70 other nations. It operates as a subsidiary of Reig Jofre Investments SL.
Share Price
$2.87
Last synced: 2026-11-13
Market Cap
$235.77M
Change (1 day)
-1.90%
Change (1 year)
-8.62%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Laboratorio Reig Jofre, S.A. (RJF)
Category
Healthcare
EPS for Laboratorio Reig Jofre, S.A. (RJF)
EPS as of June 2026 TTM: $0.09
According to Laboratorio Reig Jofre, S.A.'s latest financial reports, its current EPS (TTM) is $0.09. At the end of 2025 the company had an EPS of $0.07, a decrease compared to its 2024 EPS of $0.14.
EPS history for Laboratorio Reig Jofre, S.A. from 2003 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.09 | 33.43% |
| 2025 | $0.07 | -46.49% |
| 2024 | $0.14 | 1.96% |
| 2023 | $0.13 | 23.67% |
| 2022 | $0.11 | 42.50% |
| 2021 | $0.08 | -16.80% |
| 2020 | $0.09 | 16.32% |
| 2019 | $0.08 | -51.65% |
| 2018 | $0.16 | -4.23% |
| 2017 | $0.17 | 33.02% |
| 2016 | $0.13 | -16.91% |
| 2015 | $0.15 | 243.12% |
| 2014 | $0.04 | -46.30% |
| 2013 | $0.08 | -16,600.00% |
| 2012 | 0.00 | -100.04% |
| 2011 | $1.29 | -169.66% |
| 2010 | $-1.86 | -53.38% |
| 2009 | $-3.99 | -2,959.47% |
| 2008 | $0.14 | -84.10% |
| 2007 | $0.88 | 66.63% |
| 2006 | $0.53 | 11.36% |
| 2005 | $0.47 | 5.61% |
| 2004 | $0.45 | 87.00% |
| 2003 | $0.24 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.03 | 6,356.00% |
DE
|
|
| $6.01 | 6,332.33% |
DE
|
|
| $1.53 | 1,541.22% |
JP
|
|
| $3.66 | 3,818.63% |
CH
|
|
| $0.45 | 381.80% |
IL
|
Questions about Laboratorio Reig Jofre, S.A.'s earnings per share (EPS)
What is Laboratorio Reig Jofre, S.A.'s earnings per share (EPS)?
Laboratorio Reig Jofre, S.A.'s earnings per share (EPS) over the last twelve months is $0.09, as of Jun 2026.
What was Laboratorio Reig Jofre, S.A.'s earnings per share (EPS) in 2025?
In 2025, Laboratorio Reig Jofre, S.A.'s earnings per share (EPS) was $0.07, 50.00% less than in 2024 ($0.14).
How has Laboratorio Reig Jofre, S.A.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Laboratorio Reig Jofre, S.A.'s earnings per share (EPS) went from $0.09 to $0.07, an average decline of 4.90% a year.
How does Laboratorio Reig Jofre, S.A.'s earnings per share (EPS) compare with similar companies?
Laboratorio Reig Jofre, S.A.'s earnings per share (EPS) ($0.09) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.03.